Position in MRK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,094,807
+$127,825 QoQ
Shares Held
16,302
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#1,556
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABLES CAPITAL MANAGEMENT INC. holds $11,549,324 across 11 Drug Manufacturers - General names. MRK ranks #3 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,805 | $3,364,401 | |
| 2 | JNJ |
Johnson & Johnson
|
12,302 | $3,124,338 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
16,302 | $2,094,807 | |
| 4 | PFE |
Pfizer Inc
|
36,400 | $876,512 | |
| 5 | ABBV |
AbbVie Inc.
|
3,374 | $849,033 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,190 | $414,287 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,990 | $377,756 | |
| 8 | AMGN |
Amgen Inc
|
962 | $348,359 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,094,807 | 16,302 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,966,982 | 16,352 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,779,104 | 16,902 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,452,156 | 17,302 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,347,857 | 17,027 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,694,399 | 18,877 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,790,838 | 18,002 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,993,205 | 17,552 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,960,620 | 15,837 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,109,484 | 15,987 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,753,804 | 16,087 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,665,936 | 16,182 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $1,869,087 | 16,198 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,708,942 | 16,063 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,777,419 | 16,020 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,382,656 | 16,055 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $1,463,734 | 16,055 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $1,305,005 | 15,905 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,218,959 | 15,905 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,194,624 | 15,905 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,243,153 | 15,985 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $2,069,173 | 26,841 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,293,752 | 28,041 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $2,367,477 | 28,541 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,216,278 | 28,660 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $2,158,166 | 28,050 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||